Close Close
Sign In
Newsletters
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
Podcast Center Video Center Webcasts Resource Center Events
About ThinkAdvisor Contact Us Advertise With Us Asset & Logo Licensing Sitemap Terms of Service Privacy Policy Copyright © 2024 ALM Global, LLC. All Rights Reserved.
ThinkAdvisor

Life Health > Health Insurance > Life Insurance Strategies

Company Sets Up Hemophilia Product Access Program

By Staff Writer

X
Your article was successfully shared with the contacts you provided.

Grifols Inc. is setting up a support system for individuals with a serious hereditary disease who lose access to health coverage.

Grifols, Los Angeles, a unit of Grifols S.A., Barcelona, says its new PatientCare program will provide one kind of support for patients with hemophilia who lose insurance coverage, and another type of assistance for individuals who believe their need for assistance will be temporary.

To qualify for the program, patients must meet financial eligibility requirements and document difficulty getting health coverage, Grifols says.

The program will provide access both to therapies used to treat Hemophilia A, or Factor VIII deficiency, and Hemophilia B, which is also known as Factor IX deficiency.

More information about the program is on the Web at Document Link

NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.